First published: Mon Jun 29 2020(Updated: )
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
Credit: ics-cert@hq.dhs.gov
Affected Software | Affected Version | How to fix |
---|---|---|
Prisma | ||
Prisma | ||
Baxter Prismax Firmware | <3.0 | |
Baxter Prismax |
Sign up to SecAlerts for real-time vulnerability data matched to your software, aggregated from hundreds of sources.
CVE-2020-12037 is considered to have a high severity due to the lack of data-in-transit encryption, making it vulnerable to interception during transmission.
To fix CVE-2020-12037, ensure that data transmissions to PDMS and EMR are secured using TLS/SSL protocols.
CVE-2020-12037 affects all versions of Baxter PrismaFlex and PrisMax prior to version 3.0.
The main risk associated with CVE-2020-12037 is the potential interception of sensitive treatment data by unauthorized parties.
Yes, CVE-2020-12037 can be exploited remotely due to the lack of encryption in data transmissions.